(Total Views: 490)
Posted On: 08/19/2021 1:32:05 PM
Post# of 148908
We're going for an EUA at interim analysis, from the video it sounds like Nader is going to also try for a full approval. Since there is no approved drug for severe/critical Covid if the FDA will accept a BLA for full approval we should be able to get priority review. From the possible timeline on that we could have leronlimab approved for Covid before HIV which means every approval after Covid would be a label expansion.
(13)
(1)
Scroll down for more posts ▼